HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trisha Piontek Selected Research

belantamab mafodotin

9/2023Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma.
11/2021Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study.
1/2021Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).
12/2020Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.
12/2020Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.
10/2020Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study.
1/2020Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Trisha Piontek Research Topics

Disease

7Multiple Myeloma
09/2023 - 01/2020
2Disease Progression
11/2021 - 01/2020
1Fatigue
09/2023
1Pain (Aches)
09/2023

Drug/Important Bio-Agent (IBA)

7belantamab mafodotinIBA
09/2023 - 01/2020
4Immunoconjugates (Immunoconjugate)IBA
12/2020 - 01/2020
2Proteasome InhibitorsIBA
11/2021 - 01/2020
2Immunomodulating AgentsIBA
11/2021 - 01/2020
2B-Cell Maturation AntigenIBA
10/2020 - 01/2020
1Monoclonal AntibodiesIBA
01/2020

Therapy/Procedure

2Therapeutics
11/2021 - 01/2020
1Intravenous Infusions
01/2020